Metric Finance
LearnFAQ
LearnFAQ

Learn / KIDS

NASDAQ: KIDS

Orthopediatrics (KIDS) stock, explained like you're 5

Orthopediatrics trades on the Nasdaq under the ticker KIDS. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 565 million dollars.

Ticker
KIDS
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical/Dental Instruments
Size
Small cap, about 565 million dollars

Is Orthopediatrics a small, medium or large cap company?

No. Orthopediatrics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 565 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Orthopediatrics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves KIDS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • A children's orthopedic care company is scheduled to discuss results at 4:30 p.m. ET on Oct. 27. (Stock Titan)
  • Truist upgrades OrthoPediatrics stock to Hold with USD 26.44 consensus (ad-hoc-news.de)
  • Kids could be gifted company stocks in their Trump accounts. Here's what parents need to know. (Business Insider)
  • Kids can get donated stocks under new rule changes for Trump accounts but there's a catch (Yahoo Finance)
  • Opinion | Trump’s investment accounts for kids just got a controversial new feature (MS NOW)

Follow KIDS in your daily brief

Each trading day at 5 PM ET we post what happened to Orthopediatrics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow KIDS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Orthopediatrics stock

What does Orthopediatrics do?

Orthopediatrics trades on the Nasdaq under the ticker KIDS. It is a small cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 565 million dollars.

What is the ticker symbol for Orthopediatrics?

Orthopediatrics trades under the ticker KIDS on the Nasdaq.

What is Orthopediatrics's market cap?

Orthopediatrics is a small cap stock with a market cap of about 565 million dollars.

How does Orthopediatrics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves KIDS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow KIDS stock every day?

Add KIDS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow KIDS daily

A free brief on Orthopediatrics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • SYK · Stryker
  • BDX · Becton Dickinson & co
  • MDLN · Medline
  • RMD · Resmed

Similar stocks

  • SYKStryker
  • BDXBecton Dickinson & co
  • MDLNMedline
  • RMDResmed

Compare KIDS: KIDS vs SYK, KIDS vs BDX, KIDS vs MDLN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed